Challenges in the Neuropathological Diagnosis of Dementias
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Dementia, defined as deterioration in several cognitive domains, is a major public health problem that threatens to become the scourge of the 21th century. It is caused by dysfunction/loss of synapses and neurons inducing default neuronal networks. Consensus criteria for the diagnosis of different dementia disorders have recently been updated. Clinical diagnostic accuracy using revised research criteria and new chemical, imaging and genetic biomarkers ranges from 65 to 96% (for Alzheimer disease), with a sensitivity versus other dementias of 71 to 87% and specificity of 44 to 71%. Morphological assessment, using immunohistochemistry, molecular biological and genetic methods and based on homogenous definitions, harmonized inter-laboratory methods and assessment standards, can achieve a diagnosis/classificaion in almost 99%, without, however, clarifying the etiology of most of these disorders. The new National Institute on Aging-Alzheimer Association (ABC) guidelines for pathological diagnosis of Alzheimer disease combine βamyloid plaque phases, Braak neurofibrillary and neuritic plaque scores, also considering other pathologies. Major difficulties arise from recent separation of distinct clinico-pathological subtypes (tangleand plaque intensive, tangle predominant, limbic-predominant and -sparing) from classical Alzheimer disease. Revised research criteria are available for dementia with Lewy bodies, Parkinson disease-dementia, frontotemporal lobe degeneration, vascular cognitive impairment/dementia, prion diseases, and other neurodegenerative dementias. However, due to considerable overlap between various neurodegenerative proteinopathies and cases with mixed pathologies, human postmortem studies entail numerous biases that affect both their general applicability and the validity of correlations. Although most neurodegenerative dementias are incurable at present, concerted prospective clinico-pathological studies using validated protocols and data fusion are required to overcome the limitations of the current diagnostic framework as a basis for efficient new therapy options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 6×
“Histopathological examination of the brain establishes that AD-related lesions are present in sufficient densities to distinguish AD from age-related lesions and allows detection of other dementing disorders (Duyckaerts et al., 2009; Hyman et al., 2012; Montine et al., 2012).”
BackgroundMethodInfluentialWhen does age-related cognitive decline begin?
Salthouse, T. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.023 · Cited by 1,848 · cited 1×
“In conclusion, the aging process that results in loss of synapses and neurons may be far more detrimental for those with little cognitive/brain reserve as compared to those with a high one (Salthouse, 2009; Tucker and Stern, 2011).”
BackgroundMild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 2×
“…from "normal" aging, only a small proportion of cognitively intact aged subjects are free of AD pathology, while up to 50% may show AD-related changes or even definite AD pathology (Arriagada et al., 1992; Davis et al., 1999; Knopman et al., 2003b; Bennett et al., 2006; JL Price et al., 2009).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103 · cited 2×
“The misdiagnosis rate should be considered when estimating numbers for AD studies (Beach et al., 2012).”
BackgroundThe Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 2×
“, 2012), and (2) loss of synapses (Scheff and Price, 1993; Scheff et al., 2006; Scheff et al., 2007), between 8 and 45% of nondemented, often cognitively stable seniors were found to have AD-related pathologies (Morris et al.”
BackgroundMurray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70156-9 · Cited by 972 · cited 1×
“Hippocampal-sparing cases were younger at death; while the disease duration in all three types was similar (Murray et al., 2011).”
ResultArizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Brain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875 · cited 5×
“The concept of "preclinical AD"pathology has been solidified by in vivo PET scanning, suggesting its high frequency in normal elderly similar to that seen in clinico-pathological cohorts (Mintun et al., 2006; Villemagne et al., 2008; Hampel et al., 2010; Johnson et al., 2012; Villain et al., 2012).”
BackgroundResultInfluentialClark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855 · cited 2×
“…Aβ in vivo by [(11)C]-PIB PET is a valuable tool for the prospective evaluation of the development and progression of cognitive impairment (Kadir et al., 2011; Sojkova et al., 2011b; Villemagne et al., 2011; Beckett et al., 2012; Clark et al., 2012; Jack et al., 2012; Villain et al., 2012).”
BackgroundMethodLongitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
Yankner, B. A., Lu, T., & Loerch, P. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.092044 · Cited by 677
Neuropathology of Cognitively Normal Elderly
Knopman, D. S., Parisi, J. E., Salviati, A., Floriach-Robert, M., Boeve, B. F., Ivnik, R. J., Smith, G. E., Dickson, D. W., Johnson, K. A., Petersen, L. E., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.11.1087 · Cited by 674
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · cited 4×
“…from "normal" aging, only a small proportion of cognitively intact aged subjects are free of AD pathology, while up to 50% may show AD-related changes or even definite AD pathology (Arriagada et al., 1992; Davis et al., 1999; Knopman et al., 2003b; Bennett et al., 2006; JL Price et al., 2009).”
BackgroundInfluentialNeuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643 · cited 5×
“Increased densities of neuritic plaques and NFTs are absent in non-demented patients over age 85-90 (Polvikoski et al., 2006; Prohovnik et al., 2006; Haroutunian et al., 2008; Nelson et al., 2009; Middleton et al., 2011; Jellinger and Attems, 2012), and there is considerable overlap in the pathologies found in demente…”
BackgroundInfluentialArriagada, P. V., Marzloff, K., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.9.1681 · Cited by 638
Schulz-Schaeffer, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0711-0 · Cited by 627 · cited 15×
“, 2005) and in α-synucleinopathies, eg, Parkinson disease (PD) and dementia with Lewy bodies (DLB) (Schulz-Schaeffer, 2010), and by cholinergic neuronal and axonal abnormalities being present in aging and AD (Geula et al.”
BackgroundInfluentialNeuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616
Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603 · cited 3×
“, 2007), between 8 and 45% of nondemented, often cognitively stable seniors were found to have AD-related pathologies (Morris et al., 1996; Davis et al., 1999; Green et al., 2000; Schmitt et al., 2000; Mitchell et al., 2002; Knopman et al., 2003a; Knopman et al., 2003b; O'Brien et al., 2009; JL Price et al., 2009; Whi…”
BackgroundJack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22628 · Cited by 602
Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q., & LaFerla, F. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0490-10.2010 · Cited by 576 · cited 1×
“On the other hand, up to 50% of PD cases exhibit additional LB pathology, which is associated with a more aggressive disease course and accelerated cognitive dysfunction (Clinton et al., 2010).”
BackgroundM. Tucker, A., & Stern, Y. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745320 · Cited by 561 · cited 1×
“In conclusion, the aging process that results in loss of synapses and neurons may be far more detrimental for those with little cognitive/brain reserve as compared to those with a high one (Salthouse, 2009; Tucker and Stern, 2011).”
BackgroundMild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537 · cited 7×
“An important problem is the frequent presence of confounding processes in the aged brain that coexist with AD, as CVD, Lewy body pathology, argyrophilic grain disease, hippocampal sclerosis, and so forth, with about two-thirds of aged human brains containing non-AD-type neuropathology (Nagy et al., 1997a; White, 2009;…”
BackgroundInfluentialNeuropathologic substrates of Parkinson disease dementia
Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518 · cited 1×
“A recent clinico-pathological study showed that cortical LB/LN pathology is the most significant correlate of dementia in PD, while AD pathology, being abundant in a subset of patients, may modify the clinical phenotype (Irwin et al., 2012).”
BackgroundAlzheimer neuropathologic alterations in aged cognitively normal subjects
Davis, D. G., Schmitt, F. A., Wekstein, D. R., & Markesbery, W. R. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00008 · Cited by 516 · cited 5×
“…et al., 2000; Jentoft et al., 2011; Jellinger and Attems, 2012), and only 1.5 to 3% were scored high likelihood of AD (Nelson et al., 2009; Jentoft et al., 2011), while 18-25% met the CERAD criteria for AD (Davis et al., 1999; Schmitt et al., 2000; Knopman et al., 2003a; Knopman et al., 2003b).”
BackgroundResultInfluentialFunctional network disruption in the degenerative dementias
Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70158-2 · Cited by 481
The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi, P., Hansen, L. A., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000129697.01779.0a · Cited by 477
Kuru in the 21st century—an acquired human prion disease with very long incubation periods
Collinge, J., Whitfield, J., McKintosh, E., Beck, J., Mead, S., Thomas, D. J., & Alpers, M. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68930-7 · Cited by 474 · cited 2×
“…diseases): transmission of sCJD prions occurred through treatment with pituitary hormones pooled from human cadavers, transplantation of dura mater or cornea, the use of contaminated EEG electrodes, and by cannibalism among the Fore linguistic group in Papua New Guinea (Collinge et al., 2006).”
BackgroundAlafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467 · cited 4×
“…Disease (CERAD) protocol (Mirra et al., 1991), include the topographical staging of neuritic AD pathology (Braak and Braak, 1991), re-evaluated recently (Braak et al., 2006b; Alafuzoff et al., 2008a), as well as the progress and distribution of Aβ deposition being different (Thal et al., 2002).”
BackgroundMethodInfluentialCerebral infarctions and the likelihood of dementia from Alzheimer disease pathology
Schneider, J. A., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000118211.78503.f5 · Cited by 436
Distinguishing Alzheimer’s disease from other major forms of dementia
Karantzoulis, S., & Galvin, J. E. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.155 · Cited by 385 · cited 2×
“, 2011), and other degenerative dementias (Karantzoulis and Galvin, 2011; Lopez et al., 2011).”
BackgroundMRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Whitwell, J. L., Josephs, K. A., Murray, M. E., Kantarci, K., Przybelski, S. A., Weigand, S. D., Vemuri, P., Senjem, M. L., Parisi, J. E., Knopman, D. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324924.91351.7d · Cited by 376
The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P., & Bennett, D. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1227 · Cited by 372 · cited 9×
“These latter groups show a wide variety in the intensity and pattern of AD-related lesions and other (vascular) pathologies (Schneider et al., 2009; Stephan et al., 2012).”
BackgroundInfluential“Preclinical” AD revisited: Neuropathology of cognitively normal older adults
Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.55.3.370 · Cited by 369
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Vanderstichele, H., Bibl, M., Engelborghs, S., Le Bastard, N., Lewczuk, P., Molinuevo, J. L., Parnetti, L., Perret‐Liaudet, A., Shaw, L. M., Teunissen, C., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.07.004 · Cited by 358 · cited 4×
“A combination of the best CSF and MRI data will lead to a more precise diagnostic prediction (Vanderstichele et al., 2012; Zabel et al., 2012), and will be further increased by using multimodal techniques and novel CNS biomarkers (Bloudek et al., 2011; Abdi et al., 2012; Blennow et al., 2012;…”
BackgroundMethodInfluentialPhosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
Arai, T., Mackenzie, I. R. A., Hasegawa, M., Nonoka, T., Niizato, K., Tsuchiya, K., Iritani, S., Onaya, M., & Akiyama, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0480-1 · Cited by 345
Vascular pathology in the aged human brain
Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D. (2006) · Neurology · doi:10.1212/01.wnl.0000249130.63615.cc · Cited by 335 · cited 1×
“PD-dementia (PDD) and DLB, sharing many clinical and morphological features, are believed to form a continuum within the spectrum of LB diseases (McKeith et al., 2005; Ballard et al., 2006; Gross et al., 2008).”
BackgroundStaging and natural history of cerebrovascular pathology in dementia
Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C.-A., & Kalaria, R. N. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8e7f · Cited by 309 · cited 1×
“Another recent staging strategy proposing semiquantitative assessment of CVLs in 4 brain areas with a score ranging from I to IV/VI (Table 3) (Deramecourt et al., 2012) needs further evaluation.”
BackgroundNelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · cited 13×
“A growing body of evidence supports the idea that plaques and NFTs actually define (but not fully represent) the disease process, which also involves oxidative stress, neuroinflammation, synaptic, neuronal, and axonal dysfunction and loss (Serrano-Pozo et al., 2011).”
BackgroundInfluentialTowards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291 · cited 2×
“…disease /CVD/), despite various proposals for a categorization of major cerebrovascular lesions (CVLs) (Chui et al., 1992; Román et al., 1993; Kalaria et al., 2004; Jellinger, 2007b), a harmonization of the criteria and techniques for the assessment of cerebral lesions of presumable/possible…”
BackgroundHaroutunian, V. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1185 · Cited by 289
Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease
Bloudek, L. M., Spackman, D. E., Blankenburg, M., & Sullivan, S. D. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110458 · Cited by 282
Neuroplasticity and cognitive aging: The scaffolding theory of aging and cognition
Goh, J. O., & Park, D. C. (2009) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2009-0493 · Cited by 253 · cited 2×
“, 2013), but the mechanisms that protect the elderly from AD are unknown (Erten-Lyons et al., 2009; Goh and Park, 2009) (see Jellinger and Attems, 2013).”
BackgroundCognitive impact of subcortical vascular and Alzheimer’s disease pathology
Chui, H. C., Zarow, C., Mack, W. J., Ellis, W. G., Zheng, L., Jagust, W. J., Mungas, D., Reed, B. R., Kramer, J. H., DeCarli, C. C., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21009 · Cited by 247 · cited 2×
“Since 50 to 85% of the brains of persons who die aged 80-90+ show appreciable CVLs (Petrovitch et al., 2005), a specific problem is the impact of CVLs in relation to AD pathology (Chui et al., 2006; Giannakopoulos et al., 2007; Jellinger, 2007a, b; Schneider et al., 2007).”
BackgroundVascular pathologies and cognition in a population-based cohort of elderly people
Fernando, M. S., & Ince, P. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.004 · Cited by 239 · cited 2×
“…patients over age 85-90 (Polvikoski et al., 2006; Prohovnik et al., 2006; Haroutunian et al., 2008; Nelson et al., 2009; Middleton et al., 2011; Jellinger and Attems, 2012), and there is considerable overlap in the pathologies found in demented and non-demented patients (Fernando and Ince, 2004).”
BackgroundNelson, P. T., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Davis, D. G., Poduska, J. W., Patel, E., Mendiondo, M. S., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00244.x · Cited by 239
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
Seppälä, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., Zetterberg, H., Pyykkö, O. T., Helisalmi, S., Alafuzoff, I., Hiltunen, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563bd0 · Cited by 236
Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236 · cited 2×
“Although cognitively normal elderly may show variable neocortical AD-related pathology, in general, the number of isocortical tangles correlates best with the severity of cognitive impairment (Nelson et al., 2007; Nelson et al., 2009; Markesbery, 2010; Nelson et al., 2012).”
BackgroundAD lesions and infarcts in demented and non‐demented Japanese‐American men
Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., Nelson, J., Hardman, J., Masaki, K., Vogt, M. R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20318 · Cited by 230 · cited 9×
“The revised NIA-AA guidelines recommend reporting all macroscopic and microscopic CVLs, multiple such lesions being associated with increased likelihood of cognitive impairment (Montine et al., 2012).”
BackgroundInfluentialRelation of neuropathology to cognition in persons without cognitive impairment
Bennett, D. A., Wilson, R. S., Boyle, P. A., Buchman, A. S., & Schneider, J. A. (2012) · Annals of Neurology · doi:10.1002/ana.23654 · Cited by 220 · cited 4×
“…exhibit cognitive impairment and live "normal" lives despite displaying pathological changes that are characteristic of AD, PD, cerebrovascular disease or other disorders (Neuropathology-Group, 2001; O'Brien et al., 2009; Schneider et al., 2009; Bennett et al., 2012; Jellinger and Attems, 2012).”
BackgroundInfluentialEffect of infarcts on dementia in the Baltimore longitudinal study of aging
Troncoso, J. C., Zonderman, A. B., Resnick, S. M., Crain, B., Pletnikova, O., & O'Brien, R. J. (2008) · Annals of Neurology · doi:10.1002/ana.21413 · Cited by 219
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211 · cited 1×
“…assessment of clinical, neuroimaging, biomarker, and neuropathological data are currently under way (Cairns et al., 2010; Frisoni, 2010; Jagust et al., 2010; Trojanowski et al., 2010; Weiner et al., 2010; Jack, 2012; Johnson et al., 2012; Toledo et al., 2012; Vanderstichele et al., 2012).”
BackgroundFluid Biomarkers in Alzheimer Disease
Blennow, K., Zetterberg, H., & Fagan, A. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006221 · Cited by 208 · cited 2×
“…Zabel et al., 2012), and will be further increased by using multimodal techniques and novel CNS biomarkers (Bloudek et al., 2011; Abdi et al., 2012; Blennow et al., 2012; Doecke et al., 2012; Engelborghs and Le Bastard, 2012; Fagan and Perrin, 2012; Johnson et al., 2012; JC Price, 2012; Teipel et…”
BackgroundMethodWhite, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1178 · Cited by 193
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161560 · Cited by 186 · cited 1×
“The high frequency of mixed pathologies in demented elderly was recently confirmed (Kovacs et al., 2008; RS Wilson et al., 2012).”
BackgroundCSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182 · cited 2×
“…further increased by using multimodal techniques and novel CNS biomarkers (Bloudek et al., 2011; Abdi et al., 2012; Blennow et al., 2012; Doecke et al., 2012; Engelborghs and Le Bastard, 2012; Fagan and Perrin, 2012; Johnson et al., 2012; JC Price, 2012; Teipel et al., 2012; Toledo et al., 2012).”
BackgroundEcology of the Aging Human Brain
Sonnen, J. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.157 · Cited by 174 · cited 1×
“The burden of brain lesions and comorbidities varied widely within each study but was similar across studies (Sonnen et al., 2011).”
Alzheimer disease pathology as a host response
Castellani, R. J., Lee, H.-G., Zhu, X., Perry, G., & Smith, M. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318177eaf4 · Cited by 171 · cited 2×
“However, the suggestion that plaques and NFTs, the morphologic markers of AD, may "cause" this disorder is oversimplified or even wrong, since accumulating evidence indicates that AD pathology represents effect rather than cause or at least a host response to injury, equaling adaptative or neuroprotective reaction (Ca…”
BackgroundMIRRA, S. S., GEARING, M., MCKEEL, D. W., CRAIN, B. J., HUGHES, J. P., BELLE, G. V., & HEYMAN, A. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199405000-00012 · Cited by 156
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old
Haroutunian, V., Schnaider-Beeri, M., Schmeidler, J., Wysocki, M., Purohit, D. P., Perl, D. P., Libow, L. S., Lesser, G. T., Maroukian, M., & Grossman, H. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1211 · Cited by 154
Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)
O'Brien, R. J., Resnick, S. M., Zonderman, A. B., Ferrucci, L., Crain, B. J., Pletnikova, O., Rudow, G., Iacono, D., Riudavets, M. A., Driscoll, I., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1179 · Cited by 137
Cerebrovascular Disease Pathology and Parkinsonian Signs in Old Age
Buchman, A. S., Leurgans, S. E., Nag, S., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.111.623462 · Cited by 133
Frontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management
Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease
Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123 · cited 4×
“The AD resiliant group (pathological AD without cognitive impairment) showed preserved densities of synaptophysin-positive presynaptic terminals and dendritic spines compared with the AD-dementia group and increased densities of GFAP-positive astrocytes compared with the ADdementia group and normal controls (Arnold et…”
BackgroundResultInfluentialAD brain pathology: Vascular origins?
Launer, L. J., Petrovitch, H., Ross, G. W., Markesbery, W., & White, L. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.008 · Cited by 117
Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study
Kramer, P. L., Xu, H., Woltjer, R. L., Westaway, S. K., Clark, D., Erten-Lyons, D., Kaye, J. A., Welsh-Bohmer, K. A., Troncoso, J. C., Markesbery, W. R., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.010 · Cited by 108
Cognitive reserve, presynaptic proteins, and dementia in the elderly
Honer, W. G., Barr, A. M., Sawada, K., Thornton, A. E., Morris, M. C., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.38 · Cited by 100 · cited 1×
“Hence, greater amounts of presynaptic proteins and distinct protein-protein interactions may be components of cognitive reserve reducing the risk of dementia with aging (Honer et al., 2012).”
BackgroundNeuropathology of preclinical and clinical lateonset Alzheimer's disease
Troncoso, J. C., Cataldo, A. M., Nixon, R. A., Barnett, J. L., Lee, M. K., Checler, F., Fowler, D. R., Smialek, J. E., Crain, B., Martin, L. J., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430519 · Cited by 93
Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
Alafuzoff, I., Parkkinen, L., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Ferrer, I., Gelpi, E., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181633526 · Cited by 90
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old
Robinson, J. L., Geser, F., Corrada, M. M., Berlau, D. J., Arnold, S. E., Lee, V. M.-Y., Kawas, C. H., & Trojanowski, J. Q. (2011) · Brain · doi:10.1093/brain/awr308 · Cited by 88
SantaCruz, K. S., Sonnen, J. A., Pezhouh, M. K., Desrosiers, M. F., Nelson, P. T., & Tyas, S. L. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822e8ae9 · Cited by 79
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79 · cited 2×
“…data on the pathogenesis and pathophysiology of these diseases, showing a complex cascade of events leading from preclinical to fully developed neurodegeneration (Gotz and Gotz, 2009; Leon et al., 2010; Balducci and Forloni, 2011; Hunter et al., 2011; Petiet et al., 2011; de Calignon et al., 2012).”
BackgroundBeach, T. G., Sue, L. I., Walker, D. G., Sabbagh, M. N., Serrano, G., Dugger, B. N., Mariner, M., Yantos, K., Henry-Watson, J., Chiarolanza, G., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111340 · Cited by 74
Preclinical AD Workgroup staging: Pathological correlates and potential challenges
Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71 · cited 1×
“However, due to variable overlap, these changes may fail to distinguish between cognitively intact aged subjects from those with mild cognitive impairment (MCI) or preclinical or mild AD (Petersen et al., 2006; Markesbery, 2010; Scheff et al., 2011; Jicha et al., 2012; Mufson et al., 2012).”
BackgroundAge, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing
Dolan, D., Troncoso, J., Resnick, S. M., Crain, B. J., Zonderman, A. B., & O'Brien, R. J. (2010) · Brain · doi:10.1093/brain/awq141 · Cited by 70
McKeel, D. W., Price, J. L., Miller, J. P., Grant, E. A., Xiong, C., Berg, L., & Morris, J. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1028 · Cited by 68 · cited 2×
“, 2012), while others found that both diffuse and neuritic plaques, rather than tangles in neocortical regions distinguish nondemented and AD subjects with high sensitivity and specificity (McKeel et al., 2004).”
BackgroundClinical and research diagnostic criteria for Alzheimer's disease
Sarazin, M., de Souza, L. C., Lehéricy, S., & Dubois, B. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.004 · Cited by 64
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0466-z · Cited by 60
Self-citation“End-Stage” Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction?
Abner, E. L., Kryscio, R. J., Schmitt, F. A., SantaCruz, K. S., Jicha, G. A., Lin, Y., Neltner, J. M., Smith, C. D., Van Eldik, L. J., & Nelson, P. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101980 · Cited by 49
Neuropathology and general autopsy findings in nondemented aged subjects
Jellinger, K. A., & Attems, J. (2012) · Clinical Neuropathology · doi:10.5414/np300418 · Cited by 48 · cited 11×
“An important problem is the frequent presence of confounding processes in the aged brain that coexist with AD, as CVD, Lewy body pathology, argyrophilic grain disease, hippocampal sclerosis, and so forth, with about two-thirds of aged human brains containing non-AD-type neuropathology (Nagy et al., 1997a; White, 2009;…”
BackgroundInfluentialSelf-citationStaging of Alzheimer-Type Pathology: An Interrater-Intrarater Study
Nagy, Z., Vatter-Bittner, B., Braak, H., Braak, E., Yilmazer, D. M., Schultz, C., & Hanke, J. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106639 · Cited by 45
Polvikoski, T., Sulkava, R., Rastas, S., Sutela, A., Niinistö, L., Notkola, I.-L., Verkkoniemi, A., Viramo, P., Juva, K., & Haltia, M. (2006) · Neuroepidemiology · doi:10.1159/000090252 · Cited by 43
Nelson, P. T., Kukull, W. A., & Frosch, M. P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d8db07 · Cited by 37 · cited 4×
“These two studies and another one from the NACCR, separating "tangle intensive" and "plaque intensive" cases from "classic" AD (Nelson et al., 2010b) emphasize the need for prospective clinico-pathological studies for further elucidation of various phenotypes of AD.”
BackgroundMethodInfluentialHyperphosphorylated Tau in the Occipital Cortex in Aged Nondemented Subjects
Pikkarainen, M., Kauppinen, T., & Alafuzoff, I. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a6ee45 · Cited by 21
Models of Neurodegenerative Disease – Alzheimer’s Anatomical and Amyloid Plaque Imaging
Petiet, A., Delatour, B., & Dhenain, M. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-219-9_16 · Cited by 14 · cited 2×
“…data on the pathogenesis and pathophysiology of these diseases, showing a complex cascade of events leading from preclinical to fully developed neurodegeneration (Gotz and Gotz, 2009; Leon et al., 2010; Balducci and Forloni, 2011; Hunter et al., 2011; Petiet et al., 2011; de Calignon et al., 2012).”
Background
Cited by
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
“In addition, there is a growing appreciation, not yet incorporated into consensus-based guidelines, that the neuropathology of AD is heterogeneous [2, 18, 20, 59, 62, 76–78, 92, 104, 105, 118, 151].”
BackgroundSelf-citationThe overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“The pathophysiology of VaD has been critically reviewed recently [48,144-146].”
BackgroundResultSelf-citationPathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“On the other hand, many elderly patients exhibit morphologic changes commonly seen in AD and VaD, but do not meet the clinical criteria of dementia (see Jellinger and Attems, 2012; Jellinger, 2013).”
BackgroundResultSelf-citationChallenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Self-citation
Metadata
- Authors
- Jellinger, K.
- Venue
- International Journal of Neuropathology
- Publisher
- Columbia International Publishing
- Published
- 2013
- ISSN
- 2163-1042 (ISSN-L)
- 2163-1069
- OpenAlex
- W2330232776
- Cited by
- 15
- References
- 94
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.